Response to Lamotte et Al. "A health economic model to assess the long-term effects and cost-effectiveness of orlistat in obese type 2 diabetic patients."
- PMID: 12351513
- DOI: 10.2337/diacare.25.10.1899-a
Response to Lamotte et Al. "A health economic model to assess the long-term effects and cost-effectiveness of orlistat in obese type 2 diabetic patients."
Comment on
-
A health economic model to assess the long-term effects and cost-effectiveness of orlistat in obese type 2 diabetic patients.Diabetes Care. 2002 Feb;25(2):303-8. doi: 10.2337/diacare.25.2.303. Diabetes Care. 2002. PMID: 11815500
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
